Abbelight

Cachan, France

Medical Imaging Imaging Systems Device Development

Abbelight is the result of 10 years of academic research on new detection methods for Fluorescence Microscopy, jointly led by Sandrine Lévèque-Fort (ISMO – Paris-Saclay University) and Emmanuel Fort (Langevin Institute – ESPCI Paris). Forerunners for using Supercritical Angle Fluorescence (SAF) as a sensor for 3D imaging, the work of Sandrine and Emmanuel led to several patents and applications of SAF to different imaging techniques, including nanoscopy.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Abbelight on @MedStartr Today #Diagnostics #AllTherapeuticAreas #MedicalImaging #ImagingSystems #DeviceDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/9ApxqwK4aLg

Get Involved in Abbelight

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2016
Website: www.abbelight.com/

Disease Areas

Diagnostics All Therapeutic Areas

Technologies

3D VisualizationImaging & VisualizationNanotechnology

🌐Website

What do you think of Abbelight?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.